Polyglutamine tract binding protein-1 is an intrinsically unstructured protein

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 6, 2009, Pages 936-943

  Takahashi, Masaki ^a   Mizuguchi, Mineyuki ^a   Shinoda, Hiroyuki ^a   Aizawa, Tomoyasu ^b   Demura, Makoto ^b   Okazawa, Hitoshi ^c   Kawano, Keiichi ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Medical Research Institute   (Japan)

Author keywords

Polyglutamine; PQBP 1; Protein structure; U5 15kD; Unstructured protein

Indexed keywords

BINDING PROTEIN; POLYGLUTAMINE; POLYGLUTAMINE TRACT BINDING PROTEIN 1; RNA POLYMERASE II; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE;

CARRIER PROTEINS; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEAR PROTEINS; SURFACE PLASMON RESONANCE;

EID: 67349133614     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.03.001     Document Type: Article

References (45)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
2. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., and Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
3. Koide R., Ikeuchi T., Onodera O., Tanaka H., Igarashi S., Endo K., Takahashi H., Kondo R., Ishikawa A., Hayashi T., Saito M., Tomoda A., Miike T., Naito H., Ikuta F., and Tsuji S. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 6 (1994) 9-13
4. Nagafuchi S., Yanagisawa H., Ohsaki E., Shirayama T., Tadokoro K., Inoue T., and Yamada M. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat. Genet. 8 (1994) 177-182
5. Li S.H., McInnis M.G., Margolis R.L., Antonarakis S.E., and Ross C.A. Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics 16 (1993) 572-579
6. Margolis R.L., Li S.H., Young W.S., Wagster M.V., Stine O.C., Kidwai A.S., Ashworth R.G., and Ross C.A. DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. Brain Res. Mol. Brain Res. 36 (1996) 219-226
7. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I., Kimura J., Narumiya S., and Kakizuka A. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8 (1994) 221-228
8. Pulst S.M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., DeJong P., Rouleau G.A., Auburger G., Korenberg J.R., Figueroa C., and Sahba S. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 14 (1996) 269-276
9. Sanpei K., Takano H., Igarashi S., Sato T., Oyake M., Sasaki H., Wakisaka A., Tashiro K., Ishida Y., Ikeuchi T., Koide R., Saito M., Sato A., Tanaka T., Hanyu S., Takiyama Y., Nishizawa M., Shimizu N., Nomura Y., Segawa M., Iwabuchi K., Eguchi I., Tanaka H., Takahashi H., and Tsuji S. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 14 (1996) 277-284
10. Imbert G., Saudou F., Yvert G., Devys D., Trottier Y., Garnier J.M., Weber C., Mandel J.L., Cancel G., Abbas N., Dürr A., Didierjean O., Stevanin G., Agid Y., and Brice A. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat. Genet. 14 (1996) 285-291
11. Perez M.K., Paulson H.L., Pendse S.J., Saionz S.J., Bonini N.M., and Pittman R.N. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143 (1998) 1457-1470
12. Boutell J.M., Thomas P., Neal J.W., Weston V.J., Duce J., Harper P.S., and Jones A.L. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum. Mol. Genet. 8 (1999) 1647-1655
13. Kazantsev A., Preisinger E., Dranovsky A., Goldgaber D., and Housman D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11404-11409
14. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., and Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6763-6768
15. McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., and Fischbeck K.H. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9 (2000) 2197-2202
16. Shimohata T., Nakajima T., Yamada M., Uchida C., Onodera O., Naruse S., Kimura T., Koide R., Nozaki K., Sano Y., Ishiguro H., Sakoe K., Ooshima T., Sato A., Ikeuchi T., Oyake M., Sato T., Aoyagi Y., Hozumi I., Nagatsu T., Takiyama Y., Nishizawa M., Goto J., Kanazawa I., Davidson I., Tanese N., Takahashi H., and Tsuji S. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet. 26 (2000) 29-36
17. Cha J.H. Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23 (2000) 387-392
18. Zoghbi H.Y., and Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23 (2000) 217-247
19. Lunkes A., Trottier Y., and Mandel J.L. Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases. Essays Biochem. 33 (1998) 149-163
20. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greenwald M., Kurokawa R., Housman D.E., Jackson G.R., Marsh J.L., and Thompson L.M. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413 (2001) 739-743
21. Wyttenbach A., Swartz J., Kita H., Thykjaer T., Carmichael J., Bradley J., Brown R., Maxwell M., Schapira A., Orntoft T.F., Kato K., and Rubinsztein D.C. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum. Mol. Genet. 10 (2001) 1829-1845
22. Kegel K.B., Meloni A.R., Yi Y., Kim Y.J., Doyle E., Cuiffo B.G., Sapp E., Wang Y., Qin Z.H., Chen J.D., Nevins J.R., Aronin N., and DiFiglia M. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J. Biol. Chem. 277 (2002) 7466-7476
23. Okazawa H. Polyglutamine diseases: a transcription disorder?. Cell Mol. Life Sci. 60 (2003) 1427-1439
24. Okazawa H., Sudol M., and Rich T. PQBP-1 (Np/PQ): a polyglutamine tract-binding and nuclear inclusion-forming protein. Brain Res. Bull. 56 (2001) 273-280
25. Okazawa H., Rich T., Chang A., Lin X., Waragai M., Kajikawa M., Enokido Y., Komuro A., Kato S., Shibata M., Hatanaka H., Mouradian M.M., Sudol M., and Kanazawa I. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34 (2002) 701-713
26. Waragai M., Lammers C.H., Takeuchi S., Imafuku I., Udagawa Y., Kanazawa I., Kawabata M., Mouradian M.M., and Okazawa H. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8 (1999) 977-987
27. Waragai M., Junn E., Kajikawa M., Takeuchi S., Kanazawa I., Shibata M., Mouradian M.M., and Okazawa H. PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain. Biochem. Biophys. Res. Commun. 273 (2000) 592-595
28. Reuter K., Nottrott S., Fabrizio P., Lührmann R., and Ficner R. Identification, characterization and crystal structure analysis of the human spliceosomal U5 snRNP-specific 15 kD protein. J. Mol. Biol. 294 (1999) 515-525
29. Li X., Romero P., Rani M., Dunker A.K., and Obradovic Z. Predicting protein disorder for N-, C-, and internal regions. Genome Inform. Ser. Workshop Genome Inform. 10 (1999) 30-40
30. Romero P., Obradovic Z., Li X., Garner E.C., Brown C.J., and Dunker A.K. Sequence complexity of disordered protein. Proteins 42 (2001) 38-48
31. Hirose S., Shimizu K., Kanai S., Kuroda Y., and Noguchi T. POODLE-L: a two-level SVM prediction system for reliably predicting long disordered regions. Bioinformatics 23 (2007) 2046-2053
32. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
33. Johnson B.A. Using NMR View to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol. 278 (2004) 313-352
34. Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J. Mol. Biol. 13 (1965) 482-495
35. Semisotnov G.V., Rodionova N.A., Kutyshenko V.P., Ebert B., Blanck J., and Ptitsyn O.B. Sequential mechanism of refolding of carbonic anhydrase B. FEBS Lett. 224 (1987) 9-13
36. Kaul R., Angeles A.R., Jager M., Powers E.T., and Kelly J.W. Incorporating beta-turns and a turn mimetic out of context in loop 1 of the WW domain affords cooperatively folded β-sheets. J. Am. Chem. Soc. 123 (2001) 5206-5212
37. Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11504-11509
38. Csizmók V., Bokor M., Bánki P., Klement E., Medzihradszky K.F., Friedrich P., Tompa K., and Tompa P. Primary contact sites in intrinsically unstructured proteins: the case of calpastatin and microtubule-associated protein 2. Biochemistry 44 (2005) 3955-3964
39. Wright P.E., and Dyson H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293 (1999) 321-331
40. Dunker A.K., Brown C.J., Lawson J.D., Iakoucheva L.M., and Obradović Z. Intrinsic disorder and protein function. Biochemistry 41 (2002) 6573-6582
41. Tompa P. Intrinsically unstructured proteins. Trends Biochem. Sci. 27 (2002) 527-533
42. Shortle D. The denatured state (the other half of the folding equation) and its role in protein stability. FASEB J. 10 (1996) 27-34
43. Miron S., Duchambon P., Blouquit Y., Durand D., and Craescu C.T. The carboxy-terminal domain of xeroderma pigmentosum complementation group C protein, involved in TFIIH and centrin binding, is highly disordered. Biochemistry 47 (2008) 1403-1413
44. Liu J., and Song J. A novel nucleolar transcriptional activator ApLLP for long-term memory formation is intrinsically unstructured but functionally active. Bochem. Biophys. Res. Commun. 366 (2008) 585-591
45. Shoemaker B.A., Portman J.J., and Wolynes P.G. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8868-8873